Advertisement

rheuma plus

, Volume 18, Issue 1, pp 12–15 | Cite as

ÖGR-Jahrestagung 2018

Antiphospholipid Syndrom

State of the Art und neue Entwicklungen
aktuell
  • 34 Downloads

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Bowie EJW, Thompson JH, Pascuzzi CA (1963) Owen CA Thrombosis in SLE despite circulating anticoagulants. J Lab Clin Med 9:416–430Google Scholar
  2. 2.
    Lubbe WF, Butler WS, Palmer SJ, Liggins GC (1984) Lupus anticoagulant in pregnancy. B J Obst Gyn 91:357–363CrossRefGoogle Scholar
  3. 3.
    Harris EN, Chan JKH, Asherson RA, Aber VR, Gharavi AE, Hughes GRV (1986) Thrombosis, recurrent fetal loss and Thrombocytopenia. Arch Intern Med 146:2153–2156CrossRefGoogle Scholar
  4. 4.
    Harris EN, Hughes GRV, Gharavi AE (1987) The antiphospholipid antibody syndrome. J Rheumatol 13:210Google Scholar
  5. 5.
    Hughes GRV (1993) The antiphospholipid syndrome: ten years on Lancet. 342:341–344Google Scholar
  6. 6.
    Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, Brey R, Derksen R, Harris EN, Hughes GR, Triplett DA, Khamashta MA (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42:1309–1311CrossRefGoogle Scholar
  7. 7.
    Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA (2010) Antiphospholipid syndrome. Lancet 30;376(9751):1498–1509CrossRefGoogle Scholar
  8. 8.
    Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, Groot DEPG (2006) Koike T; Meroni PL; Reber G; Shoenfeld Y; Tincani A; Vlachoyiannopoulos PG; Krilis SA. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4(2):295–306CrossRefGoogle Scholar
  9. 9.
    Ratzinger F, Lang M, Belik S, Jilma-Stohlawetz P, Schmetterer KG, Haslacher H, Perkmann T, Quehenberger P (2016) Lupus-anticoagulant testing at NOAC trough levels. Thromb Haemost 1;116(2):235–240CrossRefGoogle Scholar
  10. 10.
    Pengo V, Biasiolo A, Pegoraro C, Cucchini U, Noventa F, Iliceto S (2005) Antibody profiles for the diagnosis of antiphospholipid syndrome. Thromb Haemost 93(6):1147–1152CrossRefGoogle Scholar
  11. 11.
    Ruffatti A, Calligaro A, Hoxha A et al (2010) Laboratory and clinical features of pregnant women with antiphospholipid syndrome and neonatal outcome. Arthritis Care Res 62:302–307CrossRefGoogle Scholar
  12. 12.
    Moore GW (2014) Recent guidelines and recommendations for laboratory detection of lupus anticoagulants. Semin Thromb Hemost 40(2):163–171CrossRefGoogle Scholar
  13. 13.
    Meroni PL, Rivolta R, Ghidoni P (1991) Histopathological findings in cases of systemic lupus erythematosus-associated antiphospholipid syndrome. Clin Rheumatol 10:211–214CrossRefGoogle Scholar
  14. 14.
    Hughson MD, McCarty GA, Brumback RA (1995) Spectrum of vascular pathology affecting patients with the antiphospholipid syndrome. Hum Patol 26:716–724CrossRefGoogle Scholar
  15. 15.
    Espinosa G, Cervera R (2015) Current treatment of antiphospholipid syndrome: lights and shadows. Nat Rev Rheumatol 11(10):586–596CrossRefGoogle Scholar
  16. 16.
    Erkan D, Yazici Y, Peterson MG, Sammaritano L, Lockshin MD (2002) A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome. Rheumatology (Oxford) 41(8):924–929CrossRefGoogle Scholar
  17. 17.
    Giron-Gonzalez JA, Garcia del Rio E, Rodriguez C, Rodriguez-Martorell J, Serrano A (2004) Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals. J Rheumatol 31(8):1560–1567PubMedGoogle Scholar
  18. 18.
    Cervera R, Bucciarelli S, Plasín MA et al (2009) Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the “CAPS Registry”. J Autoimmun 32:240–245CrossRefGoogle Scholar
  19. 19.
    Cervera R, Rodriguez-Pinto I, Article S (2014) Catastrophic antiphospholipid syndrome: task force report summary. Lupus 23(12):1283–1285CrossRefGoogle Scholar
  20. 20.
    Ruffatti A, Tonello M, Visentin MS, Bontadi A, Hoxha A, De Carolis S, Botta A, Salvi S, Nuzzo M, Rovere-Querini P, Canti V, Mosca M, Mitic G, Bertero MT, Pengo V, Boffa MC, Tincani A (2011) Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study. Rheumatology (Oxford) 50(9):1684–1689CrossRefGoogle Scholar
  21. 21.
    Bouvier S, Cochery-Nouvellon E, Lavigne-Lissalde G, Mercier E, Marchetti T, Balducchi JP, Marès P, Gris JC (2014) Comparative incidence of pregnancy outcomes in treated obstetric antiphospholipid syndrome: the NOH-APS observational study. Blood 123(3):404–413CrossRefGoogle Scholar
  22. 22.
    Yelnik CM, Laskin CA, Porter TF, Branch DW, Buyon JP, Guerra MM, Lockshin MD, Petri M, Merrill JT, Sammaritano LR, Kim MY, Salmon JE (2016) Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study results. Lupus Sci Med 3(1):e000131CrossRefGoogle Scholar
  23. 23.
    Branch DW (1994) Thoughts on the mechanism of pregnancy loss associated with the antiphospholipid syndrome. Lupus 3:275–280CrossRefGoogle Scholar
  24. 24.
    Cuadrado MJ, Bertolaccini ML, Seed PT, Tektonidou MG, Aguirre A, Mico L, Khamashta M (2014) Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS). Baillieres Clin Rheumatol 53(2):275–284Google Scholar
  25. 25.
    Arnaud L, Mathian A, Ruffatti A, Erkan D, Tektonidou M, Cervera R, … Amoura Z (2014) Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: An international and collaborative meta-analysis. Autoimmun Rev 13(3):281–291CrossRefGoogle Scholar
  26. 26.
    Tektonidou MG et al (2009) Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies. Arthritis Rheum 61(1):29–36CrossRefGoogle Scholar
  27. 27.
    Ruiz-Irastorza G, Cuadrado MJ, Ruiz-Arruza I, Brey R, Crowther M, Derksen R, Erkan D, Krilis S, Machin S, Pengo V, Pierangeli S, Tektonidou M, Khamashta M (2011) Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies. Lupus 20(2):206–218CrossRefGoogle Scholar
  28. 28.
    Dufrost V, Risse J, Zuily S, Wahl D (2016) Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature. Curr Rheumatol Rep 18(12):74.  https://doi.org/10.1007/s11926-016-0623-7 CrossRefPubMedGoogle Scholar
  29. 29.
    Cortés-Hernández J, Sáez-Comet L, Riera Mestre A, Castro Salomó A, Cuquet Pedragosa J, Ortiz-Santamaría V, Mauri PM, Ordi-Ros J (2018) Rivaroxaban Versus Warfarin As Secondary Thromboprophylaxis in Patients with Antiphospholipid Syndrome: A Randomized, Multicenter, Open-Label, Clinical Trial. Arthritis Rheumatol 70(10):Google Scholar
  30. 30.
    Fischer-Betz R, Specker C (2016) Rheumatische Erkrankungen und Schwangerschaft – Ein Ratgeber für die Praxis. University Press, Düsseldorf.Google Scholar
  31. 31.
    Specker C (2017) Antiphospholipidsyndrom. In: Fischer-Betz R, Østensen M (Hrsg) Rheumatische Erkrankungen in der Schwangerschaft. (Kapitel 6)Google Scholar
  32. 32.
    Andreoli L, Bertsias GK, Agmon-Levin N, Brown S, Cervera R, Costedoat-Chalumeau N, Doria A, Fischer-Betz R, Forger F, Moraes-Fontes MF, Khamashta M, King J, Lojacono A, Marchiori F, Meroni PL, Mosca M, Motta M, Ostensen M, Pamfil C, Raio L, Schneider M, Svenungsson E, Tektonidou M, Yavuz S, Boumpas D, Tincani A (2017) EULAR recommendations for women’s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann Rheum Dis 76(3):476–485CrossRefGoogle Scholar
  33. 33.
    Sciascia S, Branch DW, Levy RA, Middeldorp S, Pavord S, Roccatello D, Ruiz-Irastorza G, Tincani A, Khamashta M, Schreiber K, Hunt BJ (2016) The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies. Evidence and clinical judgment. Thromb Haemost 115(2):285–290CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Austria, ein Teil von Springer Nature 2019

Personalised recommendations